Summary |
|
||||||||||
Variant origin |
|
||||||||||
Variant description |
|
||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:106112Linkage analysis was performed on 209 (AKR.129P2(B6)-Apoetm1Bres x D2.129P2(B6)-Apoetm1Bres)F2 intercross mice (95 female, 114 male) using 1967 markers. The cross was generated to identify QTL related to atherosclerosis. Parental strains AKR/J and DBA/2J are atherosclerosis resistant and sensitive, respectively. Additional QTL were identified for body weight; total cholesterol and blood count parameters. Genome-wide probability values were assigned as p0.05 =significant; p<0.25 = likely, and p.025 as suggestive. Total cholesterol QTL were identified on Chromosomes 10 and 13.A significant male specific QTL, Chol15, cholesterol 15, mapped to mouse chromosome 13 with peak marker rs6244558 with a LOD=3.85, p<0.05. DBA/2J alleles conferred higher cholesterol at this locus.QTL Chol18, cholesterol 18, in both sexes combined, mapped to Chromosome 13 with peak marker rs6244558 with a LOD=4.67, p<0.15. DBA/2J alleles conferred higher cholesterol at this locus in a single sex analysis.QTL Chol16, cholesterol 16, also male specific mapped to Chromosome 10 with peak marker rs13459120 with a LOD=3.47, p<0.10. The AKR/J alleles conferred higher cholesterol at this locus. A significant male specific QTL, Wbc1, white blood count 1, mapped to Chromosome 8 to peak marker rs13479943 with a LOD=4.05, p<0.05. Wbc2, white blood cell count 2, mapped in both sexes also mapped to Chromosome 8, peaking at marker rs13479941 with a LOD=6.22, p<0.01. AKR/J alleles conferred an increase in white blood cell count at both Wbc1 and Wbc2.A significant QTL, Rbc1, red blood cell count 1, mapped in both male and female mice mapped to Chromosome 4, peaking at marker rs3657938 with a LOD=4.67, p<0.05. DBA/2J alleles conferred higher red blood cell count at this locus.A QTL, Mono1, monocyte differential 1, mapped in both sexes, mapped to Chromosome 5, peaking at marker rs6370004 with a LOD=3.01, p<0.25.A QTL, Hct1, hematocrit 1, mapped in both sexes, mapped to Chromosome 4, peaking at marker, rs3657938 with a LOD=3.89, p<0.10.A QTL Hgb1, hemaglobin 1, also mapped in both sexes to Chromosome 4, peaking at marker rs3657938 with a LOD=3.97, p<0.10.QTL Hgb2, hemaglobin 2, also mapped in both sexes, mapped to chromosome 14, LOD=3.17 at marker rs13482409, p<0.20.QTL Lymph1, lymphocyte differential 1, a male specific QTL, mapped to Chromosome 2 peaking at marker rs13476557 with a LOD=3.28, p<0.15. AKR/J alleles confer an increased percentage of lymphocytes at this locus.QTL Lymph2, lymphocyte differential 2, also male specific, mapped to Chromosome 17 peaking at maker rs13483042 with a LOD=3.07, p<0.25. DBA/2J alleles confer and increased percentage of lymphocytes at this locus.QTL Lymph3, lymphocyte differential 3, also male specific, mapped to Chromosome 4 peaking at marker rs8260738 with a LOD=3.01, p<0.25. DBA/2J alleles confer and increased percentage of lymphocytes at this locus.QTL Lymph4, lymphocyte differential 4, mapped in both sexes to Chromosome 17 at peak marker rs13483042 with a LOD=3.69, p<0.10. DBA/2J alleles confer and increased percentage of lymphocytes at this locus.QTL Lymph5, lymphocyte differential 5, also mapped in both sexes to Chromosome 2 at peak marker rs13476534 with a LOD=3.05, p<0.25.AKR/J alleles confer an increased percentage of lymphocytes at this locus. |
||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|